Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index

Journal of the American Society of Nephrology

Volumn 24, Issue 6, 2013, Pages 987-994

  Kwakernaak, Arjan J ^a   Zelle, Dorien M ^a   Bakker, Stephan J L ^a   Navis, Gerjan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; IODINE 125;

ADULT; ALBUMINURIA; ARTICLE; BODY FAT DISTRIBUTION; BODY HEIGHT; BODY MASS; BODY SURFACE; BODY WEIGHT; CENTRAL BODY FAT DISTRIBUTION; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 84878708931     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012050460     Document Type: Article

References (59)

1. Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE; PREVEND Study Group: A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41: 733-741, 2003
2. Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, Levey AS, Weiner DE: Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. AmJ Kidney Dis 52: 29-38, 2008
3. Chou CY, Lin CH, Lin CC, Huang CC, Liu CS, Lai SW: Association between waist-to-hip ratio and chronic kidney disease in the elderly. Intern Med J 38: 402-406, 2008
4. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O: Obesity and risk for chronic renal failure. J Am Soc Nephrol 17: 1695-1702, 2006
5. Bosma RJ, van der Heide JJ, Oosterop EJ, de Jong PE, Navis G: Body mass index is associated with altered renal hemodynamics in nonobese healthy subjects. Kidney Int 65: 259-265, 2004
6. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J: Blood pressure and end-stage renal disease in men. N Engl J Med 334: 13-18, 1996
7. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ: Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 278: 2069-2074, 1997
8. Fox CS, Larson MG, Leip EP, Culleton B,Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA 291: 844-850, 2004
9. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: Themetabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174, 2004
10. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140, 2005
11. Scaglione R, Ganguzza A, Corrao S, Parrinello G, Merlino G, Dichiara MA, Arnone S, D'Aubert MD, Licata G: Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. Int J Obes Relat Metab Disord 19: 403-409, 1995
12. Reid M, Bennett F, Wilks R, Forrester T: Microalbuminuria, renal function and waist:hip ratio in black hypertensive Jamaicans. J Hum Hypertens 12: 221-227, 1998
13. Kwakernaak AJ, Tent H, Rook M, Krikken JA, Navis GJ: Renal hemodynamics in overweight and obesity: Pathogenetic factors and targets for intervention. Expert Rev Endocrinol Metab 2: 539-552, 2007
14. Schmieder RE, Beil AH, Weihprecht H, Messerli FH: How should renal hemodynamic data be indexed in obesity? J Am Soc Nephrol 5: 1709-1713, 1995
15. Delanaye P, Radermecker RP, Rorive M, Depas G, Krzesinski JM: Indexing glomerular filtration rate for body surface area in obese patients is misleading: Concept and example. Nephrol Dial Transplant 20: 2024-2028, 2005
16. Wang J, Hihara E: Human body surface area: A theoretical approach. Eur J Appl Physiol 91: 425-428, 2004
17. Verbraecken J, Van de Heyning P, De Backer W, Van Gaal L: Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism 55: 515-524, 2006
18. Visser FW, Muntinga JH, Dierckx RA, Navis G: Feasibility and impact of the measurement of extracellular fluid volume simultaneous with GFR by 125I-iothalamate. Clin J Am Soc Nephrol 3: 1308-1315, 2008
19. Visser FW, Krikken JA, Muntinga JH, Dierckx RA, Navis GJ: Rise in extracellular fluid volume during high sodium depends on BMI in healthy men. Obesity (Silver Spring) 17: 1684-1688, 2009
20. Krikken JA, Lely AT, Bakker SJ, Navis G: The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int 71: 260-265, 2007
21. Bosma RJ, Kwakernaak AJ, van der Heide JJ, de Jong PE, Navis GJ: Body mass index and glomerular hyperfiltration in renal transplant recipients: Cross-sectional analysis and long-term impact. Am J Transplant 7: 645-652, 2007
22. Chagnac A,Weinstein T, HermanM, Hirsh J,Gafter U,Ori Y: The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14: 1480-1486, 2003
23. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U: Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 278: F817-F822, 2000
24. Reisin E, Messerli FG, Ventura HO, Frohlich ED: Renal haemodynamic studies in obesity hypertension. J Hypertens 5: 397-400, 1987
25. Ribstein J, du Cailar G, Mimran A: Combined renal effects of overweight and hypertension. Hypertension 26: 610-615, 1995
26. Liese AD, Hense HW, Döring A, Stieber J, Keil U: Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95. J Hum Hypertens 15: 799-804, 2001
27. Chandie Shaw PK, Berger SP,MallatM, Frölich M, Dekker FW, Rabelink TJ: Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects. Diabetes Care 30: 1840-1844, 2007
28. Mulyadi L, Stevens C, Munro S, Lingard J, Bermingham M: Body fat distribution and total body fat as risk factors formicroalbuminuria in the obese. Ann Nutr Metab 45: 67-71, 2001
29. Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA; AusDiab Steering Committee: Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 254: 555-563, 2003
30. Feldstein CA, Akopian M,Olivieri AO, Kramer AP, NasiM, Garrido D: A comparison of body mass index and waist-to-hip ratio as indicators of hypertension risk in an urban Argentine population: a hospital-based study. Nutr Metab Cardiovasc Dis 15: 310-315, 2005
31. Wajchenberg BL: Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocr Rev 21: 697-738, 2000
32. Hunley TE, Ma LJ, Kon V: Scope and mechanisms of obesity-related renal disease. Curr Opin Nephrol Hypertens 19: 227-234, 2010
33. Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG: Features of themetabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: A prospective study in Mauritius. Diabetes Care 23: 1242-1248, 2000
34. Balkau B, Sapinho D, Petrella A, Mhamdi L, Cailleau M, Arondel D, Charles MA; D.E.S.I.R. Study Group: Prescreening tools for diabetes and obesity-associated dyslipidaemia: Comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study. Eur J Clin Nutr 60: 295-304, 2006
35. Barzi F, WoodwardM, Czernichow S, Lee CM, Kang JH, Janus E, Lear S, Patel A, Caterson I, Patel J, Lam TH, Suriyawongpaisal P, Huxley R: The discrimination of dyslipidaemia using anthropometric measures in ethnically diverse populations of the Asia-Pacific Region: theObesity in Asia Collaboration. Obes Rev 11: 127-136, 2010
36. Huxley R, James WP, Barzi F, Patel JV, Lear SA, Suriyawongpaisal P, Janus E, Caterson I, Zimmet P, Prabhakaran D, Reddy S,Woodward M; Obesity in Asia Collaboration: Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 9[Suppl 1]: 53-61, 2008
37. Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, Nevitt M, Holvoet P, Newman AB: Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 165: 777-783, 2005
38. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G: Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): A cohort study. Lancet 353: 1649-1652, 1999
39. Harding AH, Day NE, Khaw KT, Bingham S, Luben R, Welsh A, Wareham NJ: Dietary fat and the risk of clinical type 2 diabetes: The European prospective investigation of Cancer-Norfolk study. Am J Epidemiol 159: 73-82, 2004
40. Ohlson LO, Larsson B, Svärdsudd K,Welin L, Eriksson H, Wilhelmsen L, Björntorp P, Tibblin G: The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34: 1055-1058, 1985
41. Hall JE: The kidney, hypertension, and obesity. Hypertension 41: 625-633, 2003
42. Campese VM, Parise M, Karubian F, Bigazzi R: Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension 18: 805-812, 1991
43. vanPaassenP,deZeeuwD,NavisG,deJongPE:Doestherenin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension? Hypertension 27: 202-208, 1996
44. Krikken JA, Bakker SJ, Navis GJ: Role of renal haemodynamics in the renal risks of overweight. Nephrol Dial Transplant 24: 1708-1711, 2009
45. Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23: 647-655, 1983
46. Apperloo AJ, de Zeeuw D, de Jong PE: Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease. Kidney Int Suppl 45: S174- S178, 1994
47. Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving HH: Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 47: 1726-1731, 1995
48. Price DA, Lansang MC, Osei SY, Fisher ND, Laffel LM, Hollenberg NK: Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan. Diabet Med 19: 858-861, 2002
49. Micklesfield LK, Goedecke JH, Punyanitya M, Wilson KE, Kelly TL: Dualenergy X-ray performs as well as clinical computed tomography for the measurement of visceral fat. Obesity (Silver Spring) 20: 1109-1114, 2012
50. Springer F, Machann J, Claussen CD, Schick F, Schwenzer NF: Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol 16: 1560-1566, 2010
51. Tahan V, Canbakan B, Balci H, Dane F, Akin H, Can G, Hatemi I, Olgac V, Sonsuz A, Ozbay G, Yurdakul I, Senturk H: Serum gammaglutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology 55: 1433-1438, 2008
52. Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ: Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 22: 437-443, 2006
53. Kotronen A, Yki-Järvinen H: Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 28: 27-38, 2008
54. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 31[Suppl 1]: S55-S60, 2008
55. Krikken JA, Dallinga-ThieGM, Navis G, Dullaart RP: Renin- angiotensinaldosterone responsiveness to low sodium and blood pressure reactivity to angiotensin-II are unrelated to cholesteryl ester transfer protein mass in healthy subjects. Expert Opin Ther Targets 12: 1321-1328, 2008
56. Donker AJ, van der Hem GK, Sluiter WJ, Beekhuis H: A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 20: 97-103, 1977
57. Apperloo AJ, de Zeeuw D, Donker AJ, de Jong PE: Precision of glomerular filtration rate determinations for long-termslope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. J Am Soc Nephrol 7: 567-572, 1996
58. Du Bois D, Du Bois EF: A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5: 303-311, discussion 312-313, 1989
59. Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D: C-reactive protein is associatedwith renal function abnormalities in a non-diabetic population. Kidney Int 63: 654-661, 2003